399 related articles for article (PubMed ID: 21186936)
1. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
Eglen R; Reisine T
Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
[TBL] [Abstract][Full Text] [Related]
2. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
McGivern JV; Ebert AD
Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
[TBL] [Abstract][Full Text] [Related]
3. Impact of new technologies for cellular screening along the drug value chain.
Möller C; Slack M
Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
[TBL] [Abstract][Full Text] [Related]
4. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
Eglen RM; Randle DH
Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
[TBL] [Abstract][Full Text] [Related]
5. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
6. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
[TBL] [Abstract][Full Text] [Related]
7. [Screening methods for ion-channels drug discovery and new ideas].
Fujii M; Ohya S; Yamamura H; Imaizumi Y
Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):229-33. PubMed ID: 22156258
[No Abstract] [Full Text] [Related]
8. An overview of drug screening using primary and embryonic stem cells.
Eglen RM; Gilchrist A; Reisine T
Comb Chem High Throughput Screen; 2008 Aug; 11(7):566-72. PubMed ID: 18694393
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.
Thorne N; Malik N; Shah S; Zhao J; Class B; Aguisanda F; Southall N; Xia M; McKew JC; Rao M; Zheng W
Stem Cells Transl Med; 2016 May; 5(5):613-27. PubMed ID: 27034412
[TBL] [Abstract][Full Text] [Related]
10. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
Rowntree RK; McNeish JD
Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
[TBL] [Abstract][Full Text] [Related]
12. Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells.
Efthymiou A; Shaltouki A; Steiner JP; Jha B; Heman-Ackah SM; Swistowski A; Zeng X; Rao MS; Malik N
J Biomol Screen; 2014 Jan; 19(1):32-43. PubMed ID: 24019252
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery through stem cell-based organoid models.
Ranga A; Gjorevski N; Lutolf MP
Adv Drug Deliv Rev; 2014 Apr; 69-70():19-28. PubMed ID: 24582599
[TBL] [Abstract][Full Text] [Related]
14. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
15. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
16. iPS cell derived neuronal cells for drug discovery.
Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening: update on practices and success.
Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
[TBL] [Abstract][Full Text] [Related]
18. Concise review: a high-content screening approach to stem cell research and drug discovery.
Xia X; Wong ST
Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
[TBL] [Abstract][Full Text] [Related]
19. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
Struzyna LA; Watt ML
Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
